Products

PayLinkr

Share one QR, get paid anywhere.

paylinkr.app Finance / Invoicing & Payments

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Creators
Hy Serure
No social account linked
Launched
9mo ago
2026-02-09 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    One QR for all of your payment links

    Feb 9 · 9mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-01-11

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
Unknown
1 QR code · All payment methods (Venmo, Zelle, PayPal, Stripe) · Basic PNG only
Pro
Unknown
Up to 10 QR codes · All payment methods (Venmo, Zelle, PayPal, Stripe) · PNG, SVG, Light/Dark variants

Trial: Start Pro Trial 7-day free trial · Observed 2026-11-07 · Pricing page

Pages & changes

Tracked since 2026-02-09

Key pages

Weekly snapshots
www.paylinkr.app/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does PayLinkr cost?
Free: Unknown; Pro: Unknown. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does PayLinkr get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is PayLinkr and what platforms does it support?
PayLinkr is catalogued under Invoicing & Payments: Share one QR, get paid anywhere. Supported platforms: Web.

Related products in this category

Finance / Invoicing & Payments

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.